ATE56139T1 - Verfahren zur herstellung einer waessrigen pharmazeutischen loesung einer organischen saeure als wirkstoff. - Google Patents

Verfahren zur herstellung einer waessrigen pharmazeutischen loesung einer organischen saeure als wirkstoff.

Info

Publication number
ATE56139T1
ATE56139T1 AT87400964T AT87400964T ATE56139T1 AT E56139 T1 ATE56139 T1 AT E56139T1 AT 87400964 T AT87400964 T AT 87400964T AT 87400964 T AT87400964 T AT 87400964T AT E56139 T1 ATE56139 T1 AT E56139T1
Authority
AT
Austria
Prior art keywords
preparation
organic acid
active substance
aqueous pharmaceutical
pharmaceutical solution
Prior art date
Application number
AT87400964T
Other languages
English (en)
Inventor
Florence Maurin
Claude Coquelet
Alain Tournoux
Original Assignee
Chauvin Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chauvin Lab Sa filed Critical Chauvin Lab Sa
Application granted granted Critical
Publication of ATE56139T1 publication Critical patent/ATE56139T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT87400964T 1986-04-30 1987-04-24 Verfahren zur herstellung einer waessrigen pharmazeutischen loesung einer organischen saeure als wirkstoff. ATE56139T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8606346A FR2598081B1 (fr) 1986-04-30 1986-04-30 Procede de preparation d'une solution pharmaceutique aqueuse d'un principe actif constitue par un acide organique
EP87400964A EP0244315B1 (de) 1986-04-30 1987-04-24 Verfahren zur Herstellung einer wässrigen pharmazeutischen Lösung einer organischen Säure als Wirkstoff

Publications (1)

Publication Number Publication Date
ATE56139T1 true ATE56139T1 (de) 1990-09-15

Family

ID=9334832

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87400964T ATE56139T1 (de) 1986-04-30 1987-04-24 Verfahren zur herstellung einer waessrigen pharmazeutischen loesung einer organischen saeure als wirkstoff.

Country Status (8)

Country Link
US (1) US4866088A (de)
EP (1) EP0244315B1 (de)
JP (1) JPH0749373B2 (de)
AT (1) ATE56139T1 (de)
DE (1) DE3764700D1 (de)
ES (1) ES2017098B3 (de)
FR (1) FR2598081B1 (de)
GR (1) GR3000838T3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2012532A6 (es) * 1988-07-15 1990-04-01 Cusi Lab Un procedimiento para la preparacion de una solucion acuosa de b-metil-4-(2' -tienilcarbonil)fenilacetato de lisina para aplicacion topica oftalmica.
JPH0248526A (ja) * 1988-08-08 1990-02-19 Sumitomo Pharmaceut Co Ltd インドメタシン注射剤およびその製造方法
JPH0723302B1 (de) * 1989-08-03 1995-03-15
CA2021441A1 (en) * 1989-08-18 1991-02-19 Alberto Ferro Process for the manufacture of parenteral application formulations
FR2670675B1 (fr) * 1990-12-20 1993-04-16 Lafon Labor Procede de preparation de formes pharmaceutiques stables a base d'acide acetylsalicylique ou de ses sels.
TW274516B (de) * 1993-11-12 1996-04-21 Ciba Geigy Ag
EP1609477B1 (de) * 1994-12-12 2011-11-09 Omeros Corporation Bespüllungslösung und deren Verwendung zur perioperativen Hemmung von Schmerzen, Entzündungen und/oder Spasmen an einer Gefässstruktur
AU4467396A (en) * 1994-12-12 1996-07-10 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm
FR2738149B1 (fr) * 1995-09-06 1997-11-14 Chauvin Lab Sa Collyre a base d'indometacine pret a l'emploi
US5744154A (en) * 1995-09-06 1998-04-28 Laboratoire Chauvin S.A. Ready-to-use indomethacin-based eye lotion
US20030191187A1 (en) * 2002-04-01 2003-10-09 Lee Fang Yu Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same
US20090136505A1 (en) * 2005-02-23 2009-05-28 Johanna Bentz Intranasal Administration of Active Agents to the Central Nervous System
JP5276591B2 (ja) * 2007-08-09 2013-08-28 千寿製薬株式会社 ピレノキシン含有二液性点眼剤
ES2588437T3 (es) * 2007-11-30 2016-11-02 Toltec Pharmaceuticals, Llc Composiciones y métodos para tratar infecciones vaginales y biopelículas vaginales patógenas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3193459A (en) * 1955-07-01 1965-07-06 Upjohn Co Steroid hemisuccinate compositions and method for extemporaneous administration
ES415972A1 (es) * 1973-06-15 1974-04-01 Inst Llorente S A Procedimiento para la preparacion de soluciones inyectablesde complejos de indicacion antineuritica, de vitaminas, co- fermentos, y sus asociaciones.
HU185926B (en) * 1979-09-27 1985-04-28 Agostne Kahan Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives
US4443432A (en) * 1981-10-05 1984-04-17 Alcon Laboratories, Inc. Ophthmalic irrigating solution
JPS58152811A (ja) * 1982-03-08 1983-09-10 Sumitomo Chem Co Ltd インドメタシン点眼組成物
JPS60184013A (ja) * 1984-03-01 1985-09-19 Yoshitomi Pharmaceut Ind Ltd 点眼剤

Also Published As

Publication number Publication date
GR3000838T3 (en) 1991-11-15
FR2598081B1 (fr) 1990-02-02
US4866088A (en) 1989-09-12
DE3764700D1 (de) 1990-10-11
ES2017098B3 (es) 1991-01-01
FR2598081A1 (fr) 1987-11-06
EP0244315A1 (de) 1987-11-04
JPS6393712A (ja) 1988-04-25
EP0244315B1 (de) 1990-09-05
JPH0749373B2 (ja) 1995-05-31

Similar Documents

Publication Publication Date Title
ATE56139T1 (de) Verfahren zur herstellung einer waessrigen pharmazeutischen loesung einer organischen saeure als wirkstoff.
DE3789435D1 (de) Verfahren zur Herstellung von Eicosapentaensäure.
ATE75779T1 (de) Verfahren zur herstellung von optisch aktiven cyanhydrinen.
ES2029853T3 (es) Un metodo para preparar una base para pomada de gel.
DE68916754D1 (de) Verfahren zur Herstellung von optisch aktiver 3-Hydroxybuttersäure.
ATE14597T1 (de) Verfahren zur enzymatischen herstellung von l-2- amino-4-methylphosphinobuttersaeure.
DE69009237D1 (de) Verfahren zur Herstellung von optisch aktiven Estern der 6-t-Butoxy-3,5-dihydroxyhexansäure.
NO870397L (no) Fremgangsmaate for fremstilling av terapeutisk aktive organiske platinakomplekser.
DE3886213D1 (de) Verfahren zur Herstellung von Antioxidant-Zubereitungen.
ATE81976T1 (de) 2-pyrimidinyl-1-piperazin-derivate zur behandlung von alkoholismus.
DE59004490D1 (de) Verfahren zur Herstellung von alpha-Fluoracrylsäurederivaten.
SE7905659L (sv) Medel for behandling av seborreiska tillstand
DE3867745D1 (de) Verfahren zur herstellung von aromatischen aldehyden.
ATE69795T1 (de) Verfahren zur herstellung von ethylenischen carbonylverbindungen.
DK325289A (da) Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet
DE69132091T2 (de) Verfahren zur Herstellung von Indolderivaten
DE3851306D1 (de) Verfahren zur Herstellung von optisch-aktiven 1,2-Diolen.
ATE105545T1 (de) Verfahren zur herstellung von alkoxyalkylidenmalonsaeureestern.
SE8501518L (sv) Farmaceutiska preparat
FI881075A0 (fi) Menetelmä optisesti aktiivisten, oikealle kiertävien okso-isoindolinyylijohdannaisten valmistamiseksi
ATE37873T1 (de) Verfahren zur herstellung optisch aktiver 1,4dihydropyridine.
IT8622822A0 (it) Otticamente attivi. processo stereoconvergente per lapreparazione di acidi carbossilici
ATE2429T1 (de) 6-imidazol-1-yl-3-hydrazino-pyridazine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE59103279D1 (de) Verfahren zur Herstellung von optisch aktiven aliphatischen Hydroxycarbonsäureestern.
DE3851942D1 (de) Verfahren zur Herstellung von optisch aktiver alpha-Isopropyl-p-chlorophenylessigsäure.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time